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Abstract Biomechanical changes in the tumor microenvironment influence tumor progression
and metastases. Collagen content and fiber organization within the tumor stroma are major
contributors to biomechanical changes (e., tumor stiffness) and correlated with tumor
aggressiveness and outcome. What signals and in what cells control collagen organization within
the tumors, and how, is not fully understood. We show in mouse breast tumors that the action of
the collagen receptor DDR2 in CAFs controls tumor stiffness by reorganizing collagen fibers
specifically at the tumor-stromal boundary. These changes were associated with lung metastases.
The action of DDR2 in mouse and human CAFs, and tumors in vivo, was found to influence
mechanotransduction by controlling full collagen-binding integrin activation via Rap1-mediated
Talin1 and Kindlin2 recruitment. The action of DDR2 in tumor CAFs is thus critical for remodeling
collagen fibers at the tumor-stromal boundary to generate a physically permissive tumor
microenvironment for tumor cell invasion and metastases.
DOI: https://doi.org/10.7554/eLife.45508.001
Introduction
In addition to inherited and acquired mutations in tumor cells, cancer development, progression,
invasion, metastases, and responses to therapy require a permissive tumor microenvironment. The
tumor microenvironment consists of activated cells, (e.g., immune, cancer associated fibroblasts
(CAFs), endothelial cells) deposited growth factors and cytokines, and extracellular matrix (ECM) and
these all differ in number, composition and function from the tissue environment surrounding normal
epithelia. For example, biophysical changes resulting from increased matrix deposition and remodel-
ing result in mechanical perturbations, such as increased tissue stiffness. Increased tumor stromal
stiffness can influence cell differentiation (transformation), cell proliferation, cell invasion and migra-
tion, and biochemical signaling by embedded growth factors (Paszek et al., 2005)
(Provenzano et al., 2008) (Schedin and Keely, 2011). Increased and altered collagen fiber produc-
tion as well as ECM collagen fiber remodeling, in particular, are major contributors to the altered
stiffness of tumors, especially in pancreatic and breast tumors.
In breast tumors, stromal collagen fiber characteristics differ significantly from their normal tissue
counterparts in amount, composition, architecture, and function (Bonnans et al., 2014). As a result,
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aggressive breast tumors are stiffer than corresponding normal tissues and this feature can be used
to detect, stage, and prognosticate, as well as limit treatment efficacy. Collagen fibers are the most
abundant protein in the extracellular matrix (ECM) of breast tumors and women with dense breasts,
due in part to increased collagen deposition, have an increased risk for developing breast cancer
and when they do their cancers are more aggressive (Aiello, 2005). Collagen fiber alignment or ori-
entation at the tumor-stromal boundary, collagen fiber thickness, length, and architecture all affect
the mechanical properties, or stiffness, of primary breast tumors and directly impact tumor invasion
and metastatic progression (Conklin et al., 2011). Indeed, a clinical tumor associated collagen signa-
ture (TACS) has been developed and correlates to aggressiveness of breast tumors. Collagen fibers
that are short, curly, and thin are correlated with benign or less aggressive tumors while thicker
fibers that align perpendicular to the tumor-stromal interface are indicative of aggressive tumors
(Provenzano et al., 2006). Despite its clinical importance how tumor associated collagen fiber orga-
nization is generated is not fully appreciated.
Accumulated data indicates that control of ECM matrix in tumors is likely multifactorial, but the
major effector cell within the tumor microenvironment most responsible for ECM matrix production
and arguably remodeling is the cancer associated fibroblast (CAF) (Bhowmick et al., 2004). In addi-
tion to producing ECM components, CAFs remodel the tumor stroma through: (1) secretion of ECM
remodeling enzymes such as collagen cross-linking enzymes (e.g., lysyl-oxidases) and proteases (e.
g., MMPs and collagenases) and (2) force mediated matrix remodeling. Other cell types within the
tumor stroma such as immune cells and tumor cells can also impact ECM remodeling either directly
(e.g., secretion of MMPs, LOX, or collagenases) or indirectly (e.g, secretion of growth factors and
cytokines that activate CAFs) (Acerbi et al., 2015). Therefore, understanding CAF cell-intrinsic regu-
lation of ECM production and collagen fiber remodeling during cancer progression and metastasis is
an important consideration not only for multiple cancers, but also other fibrotic diseases, and treat-
ment strategies for both.
In this regard, genetically engineered mouse tumor models (GEMM) and syngeneic orthotopic
transplant models have been informative. In both these models the action of a cell surface fibrillar
collagen receptor DDR2 in tumor cells and tumor stromal cells has been shown to regulate breast
cancer metastasis (Zhang et al., 2013) (Zhang et al., 2014) (Corsa et al., 2016) (Gonzalez et al.,
2017). But, in which cells within the tumor environment the action of DDR2 is important and how is
not known. Normal breast epithelium does not express DDR2, however, in invasive human breast
tumor cells DDR2 expression is induced in 50–70% of cases and is significantly correlated with poor
outcomes, particularly in aggressive TNBCs (Zhang et al., 2013) (Toy et al., 2015). DDR2 is also an
unusual receptor tyrosine kinase (RTK) (Fu et al., 2013) (Leitinger, 2014). In contrast to other RTKs
its ligand is a structural protein (fibrillar collagen) rather than a growth factor or cytokine, and its acti-
vation and inactivation kinetics are slow for reasons not understood. Despite its ligand, DDR2 is
unlikely to be a significant adhesive receptor alone, but it has been suggested that its action may
affect collagen binding Integrin affinity (Xu et al., 2012). The molecular mechanism(s) and functional
significance of this observation has not been determined.
The other major collagen receptor in tumor cells and tumor stromal cells are the collagen binding
Integrins. Genetic and pharmacologic studies have shown that Integrins are also critical for cancer
development and metastasis (Bianconi et al., 2016) (Hamidi and Ivaska, 2018). In GEMMs deletion
of Ddr2 appears to have a greater impact on breast cancer metastasis than does either a1 or a2
Integrin deletion (two a chains of collagen binding integrins), while b1 Integrin plays a critical role in
tumor initiation and maintenance (Lahlou and Muller, 2011) (Ramirez et al., 2011) (White et al.,
2004). Integrin and DDR2 have distinct, non-overlapping binding sites within fibrillar collagens and
DDR2 can be activated by collagen in the absence of integrins (Vogel et al., 1997). In contrast to
DDR2, integrins are bona fide adhesion molecules as well as signaling receptors. A major function of
integrins is in environmental mechanosensing and mechanotransducing (Sun et al., 2016), and thus,
are sensitive and responsive to changes in the mechanical properties of the cellular environment.
Here we show that genetic deletion of the Ddr2 gene in breast tumor CAFs, without altering
DDR2 expression in tumor cells, impacts their mechanotransduction properties. It does so by activat-
ing Rap1 with subsequent activation and, or recruitment of Talin1 and Kindlin2 to cell surface b1
Integrin. As a result, DDR2 is selectively required for full activation of collagen binding Integrins in
CAFs, as fibronectin activated Integrins are normal. In vivo, breast tumors in which Ddr2 is deleted
in CAFs are less stiff, have an altered collagen fiber organization particularly at the tumor-stromal
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boundary, and decreased b1 Integrin activity. These changes are associated with decreased lung
metastasis. These data indicate that the action of DDR2 is an important regulator of mechanotrans-
duction in breast tumor CAFs, critical for full activation of collagen-binding Integrins and the forma-
tion of a metastasis permissive biophysical tumor environment.
Results
The action of DDR2 within stromal cells of the primary tumor site, as
opposed to a metastatic site, impact breast cancer lung metastases
DDR2 expression in stromal cells of primary breast tumors as well as in stromal cells of lung metasta-
ses is increased, and reciprocal orthotopic syngeneic breast tumor transplant experiments have
revealed that the action of DDR2 within stromal cells of the recipient host regulate breast cancer
lung metastases (Corsa et al., 2016). The anatomic site of action (primary tumor or metastatic site
or both), the particular stromal cell type(s) responsible, and the cellular molecular mechanisms
involved are not known, however. To determine whether the action of DDR2 in metastatic sites was
critical, we determined the extent of lung colonization by wild type primary MMTV-PyMT breast
tumor cells following tail vein injection of into syngeneic Ddr2+/+ or ubiquitous Ddr2-/- hosts. There
was no difference in the number, size, or total volume of lung tumors between either recipient
(Figure 1A). In contrast, when WT (DDR2 +ve) breast tumor cells were transplanted into syngeneic
Ddr2+/+ or ubiquitous Ddr2-/- hosts there was a decrease in primary tumor volume as well as signifi-
cantly decreased number of lung metastases (Figure 1B and C). Viewed together, these results sug-
gested that the action of DDR2 in the stromal cells within the primary tumor environment, as
opposed to the action of DDR2 in stromal cells at lung metastatic site, was important in influencing
metastasis.
DDR2 affects mechanotransduction functions of CAFs
In primary breast tumors of ubiquitous Ddr2-/-; MMTV-PyMT mice the collagen fiber organization
surrounding tumor nodules is altered compared with Ddr2+/+; MMTV-PyMT breast tumors
(Corsa et al., 2016). Collagen fiber organization in breast tumors from ubiquitous Ddr2-/- mice are
more benign or less supportive of tumor invasion and spread and these mice develop significantly
Figure 1. The primary effect of DDR2 in stromal cells is at the primary tumor site not lung metastatic site. (A) Lung colonization assay. Number of
tumors per lung at 2 weeks after tail vein injection of GFP-Luciferase PyMT breast tumor cells (Ddr2+/+) into syngeneic FVB/n Ddr2 WT (Ddr2+/+) mice
(11 mice; n = 11) or ubiquitous Ddr2 null (Ddr2-/-) mice (10 mice; n = 10). (B and C) Orthotopic transplant metastasis assay. DDR2 +ve 4T1 breast tumor
cells were transplanted into the breast of syngeneic Balb/c Ddr2+/+ (12 mice; n = 12) or ubiquitous Ddr2-/- (10 mice;n = 10) recipients. Primary tumor
volume (B) and number of lung metastases (C) were scored at 3 weeks after transplant. In all experiments, tumors were scored and enumerated
histologically. Statistics were one-way ANOVA with Tukey’s post hoc test. *p<0.05, ns - no significant difference.
DOI: https://doi.org/10.7554/eLife.45508.002
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reduced lung metastases. Since CAFs are the predominant tumor stromal cell within the primary
tumor environment that controls ECM production and arguably ECM remodeling (Bhowmick et al.,
2004) and the Ddr2 gene and DDR2 protein expression is significantly upregulated in breast tumor
CAFs during cancer progression (Corsa et al., 2016) (Gonzalez et al., 2017), we asked whether the
action of DDR2 in breast tumor CAFs impacted CAF cellular functions that facilitate tumor progres-
sion and metastasis.
We isolated primary mouse CAFs (mCAFs) from Ddr2fl/fl; MMTV-PyMT (Ddr2+/+), Actin-cre;
Ddr2fl/fl; MMTV-PyMT (Ddr2-/-), and S100a4-cre (also called FSP1cre); Ddr2fl/fl; MMTV-PyMT (Ddr2-/-)
mice as well as fibroblasts from normal mouse breast (Figure 2—figure supplement 1A). In addi-
tion, Ddr2 expression was depleted in an immortalized human breast tumor CAF cell lines (hCAFs)
using shRNA expressing lentiviruses (Zhang et al., 2016) (Figure 2—figure supplement 1B). In 2D
cultures, WT CAFs produce a linear, ordered collagen fibrillar matrix while normal fibroblasts pro-
duce a more disorganized collagen matrix (Corsa et al., 2016). In mCAFs lacking DDR2 the collagen
matrix produced in culture was more like the matrix produced by normal fibroblasts: disorganized
(Figure 2—figure supplement 1C). Re-expression of WT DDR2 into Ddr2-/- mCAF reverted matrix
production to that typical of WT mCAFs: ordered and linear (Figure 2—figure supplement 1C).
CAFs adhere and spread on collagen I-coated plates and when embedded in 3D collagen I gels,
contract collagen fibers. We measured and contrasted mCAF adhesion and spreading on 2D colla-
gen I-coated plates. Ddr2-/- CAFs exhibited decreased cell spreading that could be rescued by re-
expression of WT DDR2, but not tyrosine kinase-inactive DDR2 <K608E> (Figure 2A). When Ddr2-/-
mCAFs and Ddr2 depleted hCAFs were embedded in 3D collagen I gels, gel contraction was inhib-
ited compared to WT CAFs (Figure 2—figure supplement 1D).
A possible explanation for these phenotypes could be altered focal adhesion (FA) formation and,
or function. To test this possibility, we first measured and contrasted FA size in various mouse and
human CAFs when plated on collagen I coated plates for 30 or 60 min or overnight. For all time
points examined both human CAFs depleted of Ddr2 and mouse CAFs deleted of Ddr2 exhibited
smaller FAs (Figure 2B and C ; Figure 2—figure supplement 2A). When CAFs were plated on
Fibronectin there was no difference in the size of focal adhesions (Figure 2—figure supplement
2B). Despite the difference in focal adhesion size, there was no significant difference in the number
of FAs between cells plated on collagen I (Figure 2—figure supplement 2C). Re-expression of WT
DDR2, but not collagen binding defective DDR2 <W52A>, in Ddr2 depleted hCAFs rescued this
defect (Figure 2D).
To determine if there were functional consequences as a result of these changes in CAF cell biol-
ogy, we measured the traction force generated by various CAFs on collagen I coated hydrogels.
Ddr2-depleted hCAFs exhibited dramatically reduced traction force, and this could be rescued by
re-expressing WT DDR2, but not collagen binding defective DDR2 <W52A> (Figure 2E). Consistent
with these changes in contractile properties, both Ddr2-/- mCAFs and hCAFs depleted of Ddr2
exhibited diminished pMLC activity when plated on Collagen I (Figure 2—figure supplement 2D).
The defect in pMLC activity could be rescued by re-expression of WT DDR2 but not collagen binding
defective DDR2 <W52A> (Figure 2—figure supplement 2D). These results were not a result of a
differential level of rescue isoform expression as all were expressed in equivalent amounts as deter-
mined by total cellular DDR2-YFP fluorescence (Figure 2—figure supplement 3A) and Western blot
(Figure 2—figure supplement 3B). Furthermore, all rescue isoforms were expressed on the cell sur-
face as determined by cross-linking with the cell-impermeant reagent BS3 (Figure 2—figure supple-
ment 3C).
In sum, these experiments indicated that DDR2 deficient mouse and human breast CAFs exhib-
ited altered mechanotransduction activity when plated on or in collagen I.
DDR2 is required for full activation of collagen binding b1 integrin in
CAFs
DDR2 alone is not a strong adhesive receptor (Xu et al., 2012). Integrins, however, are considered
major cellular receptors that sense and respond to changes in ECM mechanical properties
(Sun et al., 2016). Therefore, we asked whether the mechanotransducing effects of DDR2 in CAFs
could involve regulation of Integrin activity. All collagen binding Integrins contain variable a chains
and a common b1 chain. Human CAFs were plated on collagen I, fixed and stained with the 9EG7
antibody that detects active b1 Integrin in both human and mouse cells (Bazzoni et al., 1995;
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Figure 2. DDR2 influences mechanotransduction by cancer associated fibroblasts. (A) Cell Spreading Assay. Mouse breast CAFs were added to
collagen I coated plates for 30 or 180 min. Blue columns WT CAFs; red columns Ddr2-/- CAFs; green columns Ddr2-/- CAFs rescued with WT DDR2;
gray columns Ddr2-/- CAFs rescued with tyrosine kinase dead mutant DDR2 <K608E>. Cell area was determined from phase contrast image in movies.
Time = 0 was the area of each cell 10 min after plating. All values are normalized to t = 0 for each cell type which was arbitrarily set to equal 1. At least
Figure 2 continued on next page
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Su et al., 2016) or Talin1 and then super-resolution confocal microscopy was performed. The
amount of active b1-Integrin and Talin1 at adhesion sites in cellular protrusions was quantified from
images. In Ddr2 depleted hCAFs significantly less active b1 Integrin and Talin1 was present in cell
protrusions (Figure 3A and C). When active b1 Integrin-Talin1 co-localization in cell protrusions was
determined there was significantly less co-localization in Ddr2 depleted hCAFs compared with con-
trol shSCR hCAFs (Figure 3C). Like Talin1, Kindlin2 is another cytoplasmic protein recruited to Integ-
rin adhesive sites and important for full Integrin activity (Calderwood et al., 2013). Kindlin2 - active
b1 Integrin and Talin1-Kindlin2 co-localization in cell protrusion were both significantly decreased in
Ddr2 depleted hCAFs (Figure 3—figure supplement 1A and B). This result was not due to
decreased expression of b1 Integrin in Ddr2-depleted CAFs, as when attached and spread cells
were stained with an antibody that detected total b1 Integrin there was no difference in the total
amount of b1 Integrin in cell protrusions of WT versus Ddr2 depleted cells (Figure 3B ; Figure 3—
figure supplement 1C and D). Furthermore, Western blots of Ddr2 depleted hCAFs and WT hCAFs
cell extracts demonstrated that there was no significant difference in the total cellular b1 Integrin
and Talin1 levels between cells (Figure 3D). Consistent with these imaging results, the amount of
b1-Integrin and Talin1 that co-immunoprecipitated in Ddr2 depleted hCAFs plated on collagen I was
significantly reduced (Figure 3D).
b1-Integrin chains are also used by some fibronectin binding Integrins, so we asked whether this
was a general defect in b1-containing Integrin activation or selective for collagen interacting b1-con-
taining Integrins. When Ddr2 depleted hCAFs were plated on fibronectin there was no difference in
the amount of active b1-Integrin and Talin1 present at adhesion sites within cellular protrusions from
what was present in WT hCAFs (Figure 3E). Furthermore, when Ddr2-/- mCAFs and WT mCAFs were
plated on Fibronectin coated plates there was no difference in FA size noted (Figure 2—figure sup-
plement 2B and C).
These results indicated that the presence of DDR2 in CAFs influenced full activation of collagen
binding Integrins at adhesive sites within cell protrusions by controlling Talin1 and Kindlin2 activation
and, or recruitment to Integrin adhesion complexes in cell protrusions.
DDR2 controls b1 integrin activity via Rap1 mediated Talin1 and
Kindlin2 activation and recruitment to collagen binding b1 integrins
Both DDR2 and b1-Integrin localized to adhesive sites within cell protrusions, but calculation of the
Pearson’s correlation coefficient revealed that, compared to Talin1, DDR2 did not colocalize with b1-
Integrin at these sites (Figure 4A). Defects in Talin1 and Kindlin2 recruitment to cell surface Integrin
complexes in cell protrusions of Ddr2 depleted hCAFs suggested the possibility that DDR2 might
affect ‘inside-out’ regulation of Integrin activation. A significant regulator of Talin1 activation and
recruitment to cell surface Integrins is the cytosolic GTP-binding protein RAP1. When WT control
hCAFs were exposed to collagen I, RAP1 was activated (Figure 4B). In Ddr2 depleted hCAFs there
Figure 2 continued
100 cells for each genotype were analyzed. (B) Representative confocal images of focal adhesions (as detected by Vinculin (red) and F-Actin (green)
immunofluorescence) in WT (shSCR) or Ddr2-depleted (shDDR2) hCAFs plated on collagen I coated coverslips overnight. Scale bar = 10 um. (C)
Quantification of focal adhesion size of indicated hCAFs plated on collagen I coated coverslips after 30 or 60 min. (D) Quantification of focal adhesion
size of indicated hCAFs after plating on collagen I for 18 hr. For all focal adhesion measurements in each cell type and time point, >600 total focal
adhesions from 20 different cells were measured. (E) Traction forces generated by indicated hCAF plated on collagen I-coated soft polyacrylamide gels
embedded with fluorescent beads. Top row- heat map of bead displacement field overlaid on bright field image of cells; bottom row- field of
calculated forces. Scale bars = 100 um. In all panels, statistics were one-way ANOVA with Tukey’s post hoc test. Unless otherwise noted, *p<0.05,
**p<0.01, ***p<0.001, ns no significant difference.
DOI: https://doi.org/10.7554/eLife.45508.003
The following figure supplements are available for figure 2:
Figure supplement 1. DDR2 influences mechanotransduction by cancer associated fibroblasts supplement 1.
DOI: https://doi.org/10.7554/eLife.45508.004
Figure supplement 2. DDR2 influences mechanotransduction by cancer associated fibroblasts supplement 2.
DOI: https://doi.org/10.7554/eLife.45508.005
Figure supplement 3. DDR2 influences mechanotransduction by cancer associated fibroblasts supplement 3.
DOI: https://doi.org/10.7554/eLife.45508.006
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Figure 3. DDR2 is required for full activation of collagen binding b1 Integrin in CAFs. (A) Representative n-SIM super-resolution microscopy images of
control hCAFs (shSCR) or hCAFs depleted of Ddr2 (shDDR2) showing active integrin b1 (9EG7; red) and Talin1 (green) immunofluorescence after plating
cells for 15 min on collagen I coated coverslips. Quantified in graphs on right. Fluorescence of each protein at cell surface of protrusions in WT cells
was arbitrarily set = 1, and at least 20 cells for each genotype were analyzed. (B) Representative n-SIM super-resolution microscopy images of control
Figure 3 continued on next page
Bayer et al. eLife 2019;8:e45508. DOI: https://doi.org/10.7554/eLife.45508 7 of 25
Research article Cancer Biology Cell Biology
was less total RAP1 present (Figure 4B), and when corrected for the differing amounts of RAP1 pro-
tein there was significantly less activation of RAP1 in Ddr2 depleted hCAFs after plating on collagen
I (Figure 4B). To determine if defective collagen I-induced RAP1 activation by DDR2 was required
and sufficient for Talin1 recruitment, we expressed two forms of dsRed-tagged constitutively acti-
vated RAP1 (caRAP1) in WT and Ddr2 depleted hCAFs. Cells were plated on collagen I and dsRed
positive cells identified (Figure 4—figure supplement 1A). When active b1 Integrin and Talin1
expression at cell surface of cell protrusions was determined by super resolution microscopy, both
RAP1 <V12> and RAP1 <Q63E> rescued b1 Integrin surface activation as well as the recruitment of
Talin1 to surface b1 Integrin in Ddr2 depleted hCAFs (Figure 4C). In another approach WT and Ddr2
depleted hCAFs were treated with Forskolin to activate cAMP which then activates RAP1, indepen-
dent of cell surface receptors. As with caRAP1, Forskolin treatment rescued the defect in b1 Integrin
activation at the cell surface of cell protrusions as well as Talin1 recruitment to the cell surface of cell
protrusions in Ddr2 -ve cells (Figure 4—figure supplement 1B).
These results indicated that following exposure to collagen I, DDR2 activation leads to upregula-
tion of RAP1 activity which enhanced Talin1 activation and recruitment to integrin complexes in cel-
lular protrusions and subsequent full activation of collagen-binding b1 integrins. These data also
excluded a defect in the RAP1-Talin1-b1 Integrin signaling in Ddr2 depleted hCAFs.
Deletion of Ddr2 in breast tumor CAFs results in altered collagen fiber
organization, decreased tumor stiffness, and is associated with
decreased lung metastases
To determine if mechanotransduction regulation by DDR2 observed in breast tumor CAFs in ex vivo
culture was relevant in an in vivo setting, we deleted the Ddr2 gene in breast tumor CAFs and
assessed the mechanical properties of primary tumors and the extent of lung metastasis. Selective
genetic targeting of CAFs in vivo is difficult due to the now appreciated heterogeneity of tissue and
tumor fibroblasts and the non-specificity of available cre drivers (Costa et al., 2018) (Kalluri, 2016).
With these limitations in mind, we tested a number of cre expressing mice using an LSL-tdTomato
reporter mouse. Our intent was to use the cre line that expressed in the majority of breast tumor
CAFs (as defined by FAP staining). We tested Acta2-cre (aSMA-cre), Col1-cre, and S100a4-cre
(FSP1cre) mouse lines. In MMTV-PyMT breast tumors we found that FSP1cre was expressed in the
majority of CAFs (75% of FAP+ cells were red) (Figure 5—figure supplement 1A). Breast tumor epi-
thelial-derived cells (luminal K8+ and basal K14+) and endothelial cells (CD31+) did not express
FSP1cre (Figure 5—figure supplement 1A). As has been described previously, CD45+ leukocyte
cells did express FSP1cre (90% of CD45+ cells were red) (Figure 5—figure supplement 1A).
Encouraged by these results, and cognizant of the lack of specificity of FSP1cre for solely CAFs,
we generated FSP1cre; Ddr2fl/fl; MMTV-PyMT mice (Ddr2-/- FSP1cre mice) and appropriate controls.
DNA analysis of the Ddr2fl/fl allele in whole breast tumors from FSP1cre containing mice revealed
Figure 3 continued
hCAFs (shSCR) or hCAFs depleted of Ddr2 (shDDR2) showing total integrin b1 (green) immunofluorescence after plating cells for 15 min on collagen I
coated coverslips. Quantified in graph below. Fluorescence at cell surface of protrusions in WT cells was arbitrarily set = 1 and at least 20 cells were
analyzed. (C) Representative n-SIM super-resolution microscopy images of control hCAFs (shSCR) or hCAFs depleted of Ddr2 (shDDR2) showing active
integrin b1 (9EG7; red) and Talin1 (green) immunofluorescence after plating cells for 15 min on collagen I coated coverslips. Images on right are higher
resolution images of area within the white box. Quantification of active integrin b1 (9EG7) and Talin1 co-localization (Pearson’s coefficient) is presented
in graph on right. At least 20 cells of each genotype were analyzed. ***p<0.0004. (D) Coimmunoprecipitation of Talin1 and integrin b1 (upper panel)
and 5% input control (lower panel) from control hCAF (shSCR) and hCAF depleted of DDR2 (shDDR2) cells plated on collagen I coated plates (+) or no
collagen (-) for 1 hr. This a representative result of 1 of 3 separate experiments. (E) Representative n-SIM super-resolution microscopy images of control
hCAF (shSCR) or hCAF depleted of Ddr2 (shDDR2) plated on fibronectin coated coverslips for 15 min showing active integrin b1 (9EG7, red) or Talin1
(green) immunofluorescence. Bar graphs (right) are immunofluorescent quantification of active integrin b1 (left) or Talin1 (right) at cell surface of
protrusions. All analyses of total fluorescence were normalized by cell area and at least 20 cells of each genotype were analyzed. Scale bars = 10 um. In
all panels, statistics were one-way ANOVA with Tukey’s post hoc test. Unless otherwise noted, **p<0.01, ***p<0.001, ns no significant difference.
DOI: https://doi.org/10.7554/eLife.45508.007
The following figure supplement is available for figure 3:
Figure supplement 1. DDR2 is required for full activation of collagen binding b1 Integrin in CAFs supplement 1.
DOI: https://doi.org/10.7554/eLife.45508.008
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Figure 4. Collagen I stimulated DDR2 activates Rap1 that controls Talin1 activation and recruitment to collagen binding b1 Integrins. (A) n-SIM super
resolution microscopy images of Talin1 (green) and total integrin b1 (red) (left panels), DDR2-YFP (green) and total integrin b1 (red) (middle panels), or
DDR2-YFP (green) and Talin1 (red) (right panels) immunofluorescence in WT hCAFs plated on collagen I. All lower panels are a higher resolution image
of white boxed region in upper panels. Co-localization was quantified by Pearson’s coefficient which is listed below each set of panels. All analyses of
Figure 4 continued on next page
Bayer et al. eLife 2019;8:e45508. DOI: https://doi.org/10.7554/eLife.45508 9 of 25
Research article Cancer Biology Cell Biology
that the Ddr2fl/fl gene was rearranged but not in all cells, as expected (Figure 5A). Western blots of
breast tumor CAFs isolated from these mice revealed that DDR2 protein was not expressed
(Figure 5B). Deletion of Ddr2 with FSP1cre significantly reduced the number of lung metastasis,
without affecting primary tumor burden or latency (Figure 5C–E). The number of CAFs, as defined
by PDFGRb+ve cells, in Ddr2-/- FSP1cre primary breast tumors was not different from WT tumors
(Figure 5F).
When 10 to 12 week old tumor slices were stained with picosirius red to assess collagen fiber con-
tent no significant difference in overall collagen content between WT and Ddr2-/- FSP1cre tumors at
this stage of tumor development was noted (Figure 5—figure supplement 1B). However, when col-
lagen fiber organization or architecture was analyzed by second-harmonic imaging (SHG) significant
differences were noted. Compared to WT primary tumors, collagen fibers in Ddr2-/- FSP1cre primary
tumors were curlier, shorter, and thinner (Figure 5G). This pattern corresponds to a benign or less
aggressive tumor associated collagen signature (TACS1) of which there was a significant increase in
Ddr2-/- FSP1cre tumors (Figure 5H). The more aggressive collagen signature associated with tumor
cell invasion (TACS3) is the presence of thick collagen fibers perpendicular to the tumor-stromal
interface, and these were more prevalent in WT primary tumors (Provenzano et al., 2006). In
Ddr2-/- FSP1cre tumors there was a significant decrease in the TACS3 signature compared to wild
type tumors (Figure 5G and H). When collagen organization within 5 microns of the tumor-stromal
boundary was analyzed by focused ion beam scanning electron microscopy (FIB-SEM) there was less
local collagen present, and the collagen fibers present were significantly thinner and more frag-
mented in Ddr2-/- FSP1cre tumors and ubiquitous Ddr2-/- tumors (Figure 5I; quantified in Figure 5J,
also see Video 1, Video 2, and Video 3).
Since collagen fiber structure and organization within tissues and breast tumor stroma can impact
mechanical properties we determined and contrasted the stiffness of WT and Ddr2-/- FSP1cre tumors
using Atomic Force Microscopy (AFM). Overall, Ddr2-/- FSP1cre tumors were significantly less stiff
(Figure 6A and B). Propidium Iodide staining of tumor slices was used to identify tumor nodules,
tumor-stromal boundary, and stroma (Figure 6C). When the elastic modulus within tumor nodules
were compared with that at the tumor-stromal boundary, stiffness changes were only noted at the
tumor-stromal boundary (Figure 6D), a phenotype which has been linked to tumor aggression and
invasion (Acerbi et al., 2015). Consistent with the change in overall tumor stromal stiffness, pMLC
staining of tumor slices revealed significantly less overall pMLC activity in Ddr2-/- FSP1cre tumors
(Figure 5—figure supplement 1C).
In summary, analyses of Ddr2-/- FSP1cre tumors, in which the Ddr2 gene was deleted in the major-
ity of CAFs and CD45+ leukocytes, revealed that fewer ECM collagen fibers were present at the
tumor-stromal boundary and those present appeared thinner and fragmented. The functional conse-
quence of these findings was tumors of diminished stiffness, with stiffness changes most prominent
at the tumor cell-stromal boundary. These changes in the tumor stroma were associated with less
lung metastases.
Figure 4 continued
total fluorescence were normalized by cell area and at least 20 cells were analyzed. Scale bars = 5 um. (B) RAP1 activation assay. RAP1-GTP pulldown
with RAL GDS RAP1 binding domain attached to agarose was Western blotted with an anti-RAP1 antibody (upper panel), input control (5%) RAP1 level
(middle panel) and loading control (lower panel). Control hCAF (shSCR) and hCAF depleted of Ddr2 (shDDR2) cells were plated on collagen I (+) or no
collagen (-) for 15 min. GDP and GTPg negative and positive controls on right. Results were quantified by densitometry in ImageJ and normalized to b-
tubulin and total RAP1. Shown is a representative experiment of 3 replicates. (C) Representative n-SIM super-resolution microscopy images of control
hCAF (shSCR) and hCAF depleted of Ddr2 (shDDR2) transfected with dsRed-RAP1 <Q63E> or dsRed-RAP1 <V12> plated on collagen I for 15 min,
fixed, and stained for active integrin b1 (9EG7 - red) or Talin1 (green) antibodies. Scale bars = 10 um. Graph on right shows quantification of active
integrin b1:Talin1 colocalization at cell surface of cell protrusions following introduction of constitutively active versions of RAP1. At least 20 cells were
analyzed. In all panels, statistics were one-way ANOVA with Tukey’s post hoc test. Unless otherwise stated, **p<0.01, ***p<0.001, ns - no significant
difference.
DOI: https://doi.org/10.7554/eLife.45508.009
The following figure supplement is available for figure 4:
Figure supplement 1. Collagen I stimulated DDR2 activates Rap1 that controls Talin1 activation and recruitment to collagen binding b1 Integrins
supplement 1.
DOI: https://doi.org/10.7554/eLife.45508.010
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Figure 5. Deletion of Ddr2 in breast tumor CAFs results in altered collagen fiber organization and decreased lung metastases. (A) DNA PCR
genotyping of Ddr2 alleles from whole tumors from indicated mice. (B) Western blot of CAFs isolated from MMTV-PyMT (WT) or FSP1cre; Ddr2fl/fl;
MMTV-PyMT (Ddr2-/- FSP1cre) mice with the indicated antibodies. (C) Number of total lung metastases in MMTV-PyMT (WT) (n = 18 mice) or FSP1cre;
Ddr2fl/fl; MMTV-PyMT (Ddr2-/-; FSP1cre) (n = 10 mice) mice at termination (@20 weeks or when a single tumor reached 2 cm). **p=0.0095. All mice
Figure 5 continued on next page
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In vivo, the presence of DDR2 in primary breast tumor CAFs and tumor
cells controls full b1 Integrin activation
To determine whether the action of DDR2 in breast tumor CAFs controlled b1 Integrin activity in
vivo we freshly isolated primary MMTV-PyMT breast tumor organoids (200–500 cells) from WT, ubiq-
uitous Ddr2-/-, and FSP1cre; Ddr2-/- breast tumor bearing mice and immediately cultured these in 3D
collagen I matrices under hypoxic conditions (Hwang et al., 2019). Tumor organoids were at no
time exposed to plastic tissue culture plates. Tumor organoids were then stained with 9EG7 b1
Integrin antibody that recognizes activated Integrin. FAP staining was utilized to identify CAFs, and
a control b1 Integrin antibody used to identify total b1 Integrin. In WT breast tumor organoids
embedded within collagen I there was abundant active b1 Integrin present in both CAFs (FAP +ve)
and tumor cells (FAP -ve) (Figure 7A; quantified in D and E). In contrast, in Ddr2-/- FSP1cre tumor
organoids there was significantly decreased active b1 Integrin level in CAFs, while still present and
unchanged in tumor cells that are Ddr2+/+ in these mice (Figure 7B; quantified in D and E). In ubiqui-
tous Ddr2-/- tumor organoids (all cells Ddr2-/-) active b1 Integrin level was decreased in both CAFs
and tumor cells (Figure 7C; quantified in D and E). These results were not a result of a decrease in
b1 Integrin level in Ddr2-/- cells or a change in the number of CAFs present between differing geno-
types (Figure 7A–D). These results indicated
that the action of DDR2 in CAFs and tumor cells
within primary breast tumors, in vivo, regulate
b1 Integrin activation in response to collagen I
exposure.
Discussion
The action of the fibrillar collagen receptor
DDR2 in CAFs, and possibly other cells (see
later), within the primary stroma was found to be
a critical regulator of breast tumor ECM collagen
fiber organization and tumor stiffness. FSP1cre
mediated deletion of Ddr2 in MMTV-PyMT
breast tumors resulted in tumors with reduced
stiffness, particularly at the tumor-stromal
boundary, and significantly altered collagen fiber
organization again particularly at the tumor-stro-
mal boundary. These changes were associated
Figure 5 continued
were >99% FVB/n. Lung tumors were enumerated histologically. (D) Primary tumor growth rate in MMTV-PyMT (WT) (n = 18 mice) or FSP1cre; Ddr2fl/fl;
MMTV-PyMT (Ddr2-/- FSP1cre) (n = 10 mice) as represented by time in weeks to end stage (single tumor 2 cm in largest dimension). (E) Total primary
tumor burden in WT; MMTV-PyMT (WT) (n = 18 mice) or FSP1cre; Ddr2fl/fl; MMTV-PyMT (Ddr2-/- FSP1cre) (n = 10 mice). Represented as the total
volume of all primary tumors per mouse. (F) FACS quantification of percent PDGFRa positive cells (i.e., CAFs) per total primary tumor in size- and age-
matched MMTV-PyMT (WT) or FSP1cre; Ddr2fl/fl; MMTV-PyMT (Ddr2-/- FSP1cre) tumors. Four tumors each from four different mice were analyzed (total
of 16 tumors). (G) Representative second harmonic images (SHG) of 10–12 week MMTV-PyMT (WT) or FSP1cre; Ddr2fl/fl; MMTV-PyMT (Ddr2-/- FSP1cre)
tumors. Scale bars = 100 um. (H) Quantification of TACS1 and TACS2/3 phenotype in tumor analyzed in (H). Six tumors from three different mice per
genotype were analyzed (total of 18 tumors). *p<0.05. (I) 2D en face rendering of 3D reconstructed FIB-SEM images of tumor-stromal boundary (2–5
mM) from 12 week old MMTV-PyMT (WT), ubiquitous Ddr2-/- null; MMTV-PyMT, or Ddr2-/-; FSP1cre; MMTV-PyMT tumors. Collagen fibers are green.
Three tumors of each genotype were analyzed (n = 3 for each). See also Videos 1, 2 and 3. (J) Quantification of fiber width in pixels relative to WT from
FIB-SEM images in (I) for indicated tumors (n = 3 for each genotype). Fibers were quantified with CT-FIRE software (LOCI, Madison, WI). ****p<0.0001,
**p=0.0041. In all panels, statistics were one-way ANOVA with Tukey’s post hoc test. Unless otherwise noted, *p<0.05, **p<0.01, ***p<0.001, ns no
significant difference.
DOI: https://doi.org/10.7554/eLife.45508.011
The following figure supplement is available for figure 5:
Figure supplement 1. Deletion of Ddr2 in breast tumor CAFs results in altered collagen fiber organization and decreased lung metastases supplement
1.
DOI: https://doi.org/10.7554/eLife.45508.012
Video 1. FIB-SEM of WT PyMT tumor breast tumor
cell-stromal boundary. This is a 360˚ depiction of a
Focused Ion Beam Scanning Electron Micrograph (FIB-
SEM) of the tumor-stromal boundary of a WT PyMT
breast tumor. Collagen fibers are in green. Views are
within 2 mm from the tumor cell surface.
DOI: https://doi.org/10.7554/eLife.45508.013
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with a significant decrease in lung metastases.
Isolated CAFs from these mouse tumors lack
expression of DDR2, as well as human breast tumor CAFs depleted of Ddr2 exhibit decreased
mechanotransduction properties. Their cell spreading on collagen I was decreased and formed
smaller FAs without any change in the number of FAs, exhibited decreased collagen I gel contraction
in 3D, generated reduced traction forces on collagen I coated hydrogels, and produced an altered
collagen matrix. All these phenotypes could be reversed by re-expression of WT DDR2. DDR2 was
found to be important for the full activation of collagen binding b1-containing Integrins in CAFs in
culture and in CAFs and tumor cells within primary breast tumors in vivo. DDR2 influenced collagen
binding b1 Integrin activity by regulating RAP1 mediated Talin1 and Kindlin2 activation and, or
recruitment to Integrin complexes at surface adhesion sites. In vivo, breast tumors deleted of Ddr2
in CAFs or ubiquitously in all cells within tumors exhibit decreased b1 Integrin activation in CAFs,
and tumor cells (and CAFs), respectively.
In addition to regulating Integrin-based mechanotransduction, the action of DDR in CAFs also
affects mRNA expression of collagen genes as well as collagen modifying enzymes such as lysyl oxi-
dases and MMPs (Corsa et al., 2016) that can also contribute to altered matrix collagen fibers,
tumor fibrosis and associated with enhanced metastasis (Cox et al., 2013). Indeed, FIB-SEM analysis
(Figure 5I and J; Video 1, Video 2, and Video 3) revealed that within 2–5 microns of the tumor-
stromal interface there was less collagen and the collagen fibers present in Ddr2 deficient tumors
were thinner and appeared more fragmented. Interestingly, corresponding trichrome or Sirius red
histologic quantification of collagen fibers in the same tumors analyzed by FIB-SEM revealed no dif-
ference between Ddr2-/- and WT tumors. SHG analysis of collagen fiber orientation, length, and
thickness in the same tumors as above did note changes in collagen fiber structure when Ddr2 was
deleted from CAFs, like in the FIB-SEM result.
In breast tumors, FSP1cre is expressed not only in CAFs but in the majority of CD45+ myeloid
cells. Thus, we cannot exclude a contribution of DDR2’s action in myeloid cells as contributing to the
altered CAF function in vivo or altered ECM remodeling in vivo. Inflammatory modulators secreted
by cancer associated myeloid derived cells can affect tumor ECM directly (e.g., MMPs) or indirectly
through cytokine secretion that activate CAFs (Ruffell et al., 2012). Moreover, DDR2 has been
reported to be expressed in neutrophil cell lines where it regulates migration or chemotaxis through
collagen fibers (Afonso et al., 2013), as well as in dendritic cell lines (Poudel et al., 2012). However,
in ubiquitous Ddr2-/- breast tumors there were no differences in the numbers of immune cell types
observed compared to WT tumors (Corsa et al., 2016). The effect of reciprocal bone marrow trans-
plantation of WT bone marrow into in Ddr2-/-; MMTV-PyMT mice or Ddr2-/- bone marrow into WT
MMTV-PyMT mice upon breast cancer metastasis and primary tumor ECM architecture and mechani-
cal properties will address this possibility. Regardless, the accumulated cellular and in vivo data
Video 2. FIB-SEM of ubiquitous Ddr2-/- PyMT breast
tumor cell-stromal boundary. This is a 360˚ depiction of
a Focused Ion Beam Scanning Electron Micrograph
(FIB-SEM) of the tumor-stromal boundary of a
ubiquitous Ddr2-/- PyMT breast tumor. Both tumor cells
and stromal cells are deleted of Ddr2. Collagen fibers
are in green. Views are within 2 mm from the tumor cell
surface.
DOI: https://doi.org/10.7554/eLife.45508.014
Video 3. FIB-SEM of WT PyMT tumor. This is a
360˚ depiction of a Focused Ion Beam Scanning
Electron Micrograph (FIB-SEM) of the tumor-stromal
boundary of a Ddr2fl/fl; FSP1cre; PyMT breast tumor.
Tumor stromal CAFs are deleted of Ddr2. Tumor cells
are Ddr2+/+. Collagen fibers are in green. Views are
within 2 mm from the tumor cell surface.
DOI: https://doi.org/10.7554/eLife.45508.015
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Figure 6. Deletion of Ddr2 in breast tumor CAFs results in decreased tumor stiffness. (A) Compiled total tumor stiffness measurements represented as
a histogram fit with a Gaussian curve (kPA, Young’s elastic modulus) for WT PyMT (blue line) and Ddr2-/- FSP1cre (red line) tumors. Six (6) breast tumors
from six different mice were analyzed for each genotype. (B) Bar graph quantifying average of tumor stiffness (elastic modulus) for WT PyMT primary
breast tumors and Ddr2-/- FSP1cre primary breast tumors. Six (6) breast tumors from six different mice were analyzed as in (A) to generate the averages.
Figure 6 continued on next page
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presented herein lend strong support for the mechanotransduction actions of DDR2 in CAFs as likely
being a significant contributor to breast tumor mechanical properties (e.g., stiffness). We can
exclude the action of DDR2 in tumor cells as contributing to breast tumor stiffness since deletion of
Ddr2 in breast epithelial cells only, with either MMTV-Cre or K14-Cre, did not affect primary tumor
matrix production or organization (Corsa et al., 2016).
Growth factor RTK signaling can increase integrin expression, activation, and recycling. Integrin
signals also affect growth factor RTK signaling (Ivaska and Heino, 2011). Most examples of growth
factor RTK activation of Integrins occurs at the cell surface through complex formation with Integrins
or possibly during endocytosis and recycling of receptor/Integrins (Ivaska and Heino, 2011). By
super resolution confocal microscopy or co-immunoprecipitation experiments we did not find any
supportive evidence that DDR2 and collagen binding Integrins form complexes in cells. Whether
DDR2 is endocytosed and recycled, and if so, what the functional consequences are has not been
determined. A report has suggested that DDR1b is endocytosed and recycled to the cell surface
and that the onset of endocytosis precedes receptor phosphorylation, suggesting that signaling
could occur in intracellular vesicles (Mihai et al., 2006). Overexpression of DDR2 in HEK293 cells,
cells that do not endogenously express DDR2, increase a1b1 and a2bl integrin affinity without
affecting the cell surface levels of either Integrin (Xu et al., 2012). The molecular basis for this obser-
vation and the functional significance were not determined.
During breast cancer development and progression endogenous DDR2 expression is upregulated
in CAFs and appears to be critical for their activation (Corsa et al., 2016) (Gonzalez et al., 2017).
Herein, we show that DDR2, in breast tumor CAFs, controls collagen binding Integrin activation by
activating RAP1 to regulate Talin1 and Kindlin2 activity and, or recruitment to cell surface integrin.
Talin1 and Kindlin2 activation and recruitment to cell surface b1 Integrin can be regulated by other
positive and negative interactions (Calderwood et al., 2013) (Das et al., 2014), but since constitu-
tively activated RAP1 and Forskolin treatment rescued the defect almost entirely it is less likely that
DDR2 influences these pathways. Precisely how DDR2 activates RAP1 remains to be determined.
Inside-out RAP1 signaling regulating Talin1 mediated integrin activation has been well described
and shown to be important in hematopoietic cells (Lagarrigue et al., 2016), and cultured cells
(Calderwood et al., 1999). But in mesenchymal cells within tissues, in vivo, where cells such as CAFs
are embedded in the presence of excess Integrin ligand (e.g., collagen I), it has been more difficult
to ascertain whether the contribution of inside-out signaling to integrin activation is present and
important (Klapholz and Brown, 2017). Herein we show that in the absence of full Talin1 activation
in response to collagen activated DDR2 there are clear functional sequelae in mesenchymal cells in
culture and in tumor progression in vivo.
Many, if not most, of the observed defective mechanobiologic properties of Ddr2-/- CAFs in vari-
ous culture systems and Ddr2-/- tumors in vivo are likely to be manifestations of defective collagen
binding b1 integrin activity rather than other DDR2 signaling pathways. DDR2 signaling also regu-
lates the protein level, subcellular localization, and action of SNAIL1, an important mesenchymal cell
transcriptional regulator (Zhang et al., 2013) (Stanisavljevic et al., 2015). SNAIL1 is a critical regula-
tor of the fibrogenic response of fibroblasts and CAFs (Stanisavljevic et al., 2015) (Zhang et al.,
2016). Moreover, mechanical signals (e.g., matrix stiffness) also regulates SNAIL1 levels and function
(Zhang et al., 2016). As a result, the overall tumor matrix organization controlled by DDR2 signaling
Figure 6 continued
***p=0.0008. (C) Image of Propidium Iodine staining of a tumor slice that was used to identify tumor core (T), tumor-stromal boundary (T–S), and
stromal compartments (S) regions used for measurements of stiffness. (D) Representative AFM stiffness heat map from MMTV-PyMT (WT) (left two
panels) or FSP1cre; Ddr2fl/fl; MMTV-PyMT (Ddr2-/- FSP1cre) (right two panels) breast tumors. In each set of panels, tumor core (left) and tumor-stromal
boundary (right) measurements are shown. (E) Compiled stiffness data of tumor core (left) or tumor-stroma boundary (middle) for MMTV-PyMT (WT –
blue lines and blue columns) or FSP1cre; Ddr2fl/fl; MMTV-PyMT (Ddr2-/- FSP1cre - red lines and red columns) tumors. Data are represented as the
Gaussian curve which was fitted to a histogram. Right is a bar graph showing averages of data for both tumor nodules and tumor-stromal boundary.
***p=0.0003. E = Young’s elastic modulus. Six (6) tumors from six different mice per genotype were analyzed and data plotted are the top 100 best
fitting curves per group. The Hertz method was used to calculate elasticity and Poisson’s ratio of 0.5 was used to calculate Young’s elastic modulus. In
all panels, statistics were one-way ANOVA with Tukey’s post hoc test. Unless otherwise noted, *p<0.05, **p<0.01, ***p<0.001, ns no significant
difference.
DOI: https://doi.org/10.7554/eLife.45508.016
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Figure 7. In vivo, the presence of DDR2 in primary breast tumor CAFs controls full b1 Integrin activation. WT (A), Ddr2-/- FSP1cre (B), and ubiquitous
Ddr2-/-(C) breast tumor organoids were isolated from 12 week primary tumors and immediately placed in a 3D collagen I microfluidic device under
hypoxic conditions. After 48 hr immunofluorescence staining for active b1Integrin (red) and FAP (CAFs -green) (left and middle panels) or total
b1Integrin (red) (right panel) were performed on organoids in the device. Organoids were also stained with DAPI to identify nuclei. The middle panels
Figure 7 continued on next page
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in tumors, and CAFs specifically, likely involves both its regulation of collagen binding b1 Integrin
and SNAIL1. Activation of DDR2 by fibrillar collagens, as defined by tyrosine phosphorylation of the
cytoplasmic tail, is slow (hours) and sustained (hours - days) for reasons that are unclear (Fu et al.,
2013). DDR2 signals that stabilize SNAIL1 protein in CAFs takes 4–6 hr of exposure to collagen I in
cultured cells (Zhang et al., 2016). In contrast regulation of collagen binding b1 integrin by DDR2
was apparent within minutes (15–30 min) yet requires the kinase activity of DDR2. This suggests that
the DDR2 signaling pathway regulating RAP1 and integrin activity could be distinct from that regu-
lating SNAIL1 activation.
In summary, we provide evidence and mechanism for the action of the collagen binding receptor
DDR2, primarily in cancer associated fibroblasts, as a critical pathway controlling the tumor permis-
sive ECM that forms in aggressive breast cancers and that facilitates or supports tumor cell invasion,
migration and metastasis. We also show that inside-out regulation of collagen binding Integrin
occurs in mesenchymal cells and in vivo and can have significant impact upon cancer progression to
metastasis. As such DDR2 could represent an important therapeutic target to prevent cancer metas-
tasis. Our results also shed light into how the action of DDR2 in tissue fibroblasts may contribute to
other organ fibrosis pathologies in response to injury or inflammation (Zhao et al., 2016) (DeLeon-
Pennell, 2016).
Materials and methods
Cells utilized
Immortalized human breast tumor cancer associated fibroblasts (hCAFs) were kindly provided by Dr.
S. McCallister (Harvard Medical School). Generation of control shSCR human breast tumor CAFs and
hCAF cells depleted of Ddr2 with shRNA (shDDR2) have been described previously (Zhang et al.,
2016). Primary MMTV-PYMT tumor cells were isolated as previously described (Corsa et al., 2016).
To isolate primary mouse breast tumor cancer associated fibroblasts (mCAFs), MMTV-PyMT breast
tumors were dissected, minced, and minced pieces transferred to ~20 mL of digestion media per
tumor (DMEM, 1% fbs, 0.2% Collagenase A (Roche), 0.2% trypsin (Gibco 27250–018), 50 mg/mL gen-
tamycin, 5 mg/mL insulin) and rocked at 37 degrees for 30–45 min. The digested tissue was then
washed twice with serum free media and treated with DNAse for 5 min at room temperature. Tissue
was resuspended in ice-cold serum free media and serially centrifuged four times. Single cell frac-
tions were collected and plated for 25–30 min in DMEM, 10% fbs at 37 degrees Celsius, 5% CO2,
20% O2. CAFs will adhere to the plate while other cells will not. The supernatant and non-adherent
cells were removed and CAFs were maintained in DMEM, 10% fbs at 37 degrees Celsius, 5% CO2,
20% O2. All spontaneously immortalized primary CAF cell lines were submitted to FACS with
PDGFRa antibodies. All cell lines utilized were Mycoplasma free as determined by Q-PCR analyses
every 6 months.
ECM synthesis by cultured CAFs and analysis
Human CAFs were plated to confluence on 12 mm glass coverslips in DMEM supplemented with
10% FBS and 50 mg/ml ascorbic acid, and media was changed daily for 7 days. Cells were then lysed
on day 7 (25 mmol/L Tris-HCl, pH 7.4; 150 mmol/L sodium chloride; 0.5% Triton X-100; and 20
mmol/L ammonia hydroxide) for 3–5 min. Cellular debris was carefully washed away with 1X PBS.
Resultant cell free ECMs were fixed in 4% paraformaldehyde for 15 min at room temperature and
then blocked with 5% FBS in 1X PBS. ECMs were then incubated in mouse anti-fibronectin antibody
(diluted 1:100, BD Biosciences) overnight at four degrees, washed twice, and then incubated in goat
Figure 7 continued
are higher resolution images of parts of the left panels. (D) Quantification of total fluorescence per tumor organoid for indicated antibodies in each set.
Blue columns – WT tumor organoids; red columns - Ddr2-/- FSP1cre tumor organoids, green columns - ubiquitous Ddr2-/- tumor organoids. (E)
Quantification of total fluorescence of active b1 integrin (9EG7) in only FAP+ cells (i.e., CAFs) in WT (blue), Ddr2-/- FSP1cre (red), and Ubiquitous Ddr2-/-
tumor organoids. From 2 different mice 10–20 tumor organoids per genotype were analyzed. In all panels, statistics were one-way ANOVA with Tukey’s
post hoc test. Unless otherwise noted, *p<0.05, **p<0.01, ***p<0.001, ns - no significant difference.
DOI: https://doi.org/10.7554/eLife.45508.017
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anti-mouse AlexaFluor 488 secondary (diluted 1:500, Life Technologies), washed four times,
mounted in Vectashield (VWR, 101098–044), and sealed with nail polish. Immunofluorescence was
analyzed on a confocal microscope (LSM 700; Carl Zeiss, Jena, Germany) at room temperature with
Zen 2009 software. ImageJ was used to adjust brightness and contrast.
Collagen gel contraction assay
two  105 CAFs were embedded in 100 ul of 1 mg/ml collagen one gel (Rat tail collagen, Corning
CB354249) which was then spread with a pipet tip into the well of glass bottom 12 mm Mattek
dishes. The gel was allowed to solidify at 37 degrees Celsius for 20 min after which 2 mL of
DMEM+ 10% fbs was added and gels were gently detached with a pipet tip. Gels were imaged after
3 days, and percent contraction was calculated relative to initial gel area by tracing in ImageJ.
Western blotting
Cells were lysed in 1X RIPA buffer supplemented with 1 mM PMSF, 1 mM sodium vanadate, 1 mM
sodium fluoride, and 10 ug/ml each aprotinin and leupeptin. Lysates were sonicated twice for 30 s
and centrifuged at 14,000 RPM, 10 min. Cleared lysates were separated by SDS-PAGE, transferred
onto PVDF membrane, and blocked for 1 hr at room temperature in 5% non-fat dry milk, 1X TBS-
0.5% Tween. Membranes were incubated in primary antibody overnight at four degrees with gentle
agitation, washed twice with TBS-0.5% Tween, and incubated with anti-mouse or anti-rabbit HRP
secondary antibody for one hour at room temperature. Membranes were then washed four times
with TBS-0.5% Tween and developed with ECL (Pierce, 32106). For use of specific antibodies see
Table 1.
Co-Immunoprecipitation
Tissue culture dishes were coated with 50 mg/mL collagen in water and allowed to dry overnight at
room temperature. The next day, dishes were blocked with 1% BSA for 1 hr at room temperature
and then sterilized under UV light for 20 min. Cells were serum starved overnight and then removed
from plates non-enzymatically. Cells were allowed to adhere for 1 hr and then lysed in 20 mM Tris,
pH 7.5, 1% Triton X-100, 0.1% SDS, 150 mM CaCl2 supplemented with 1 mM PMSF, 1 mM sodium
Table 1. Antibodies used for Western blot, IF, and IP.
Antibody Source Application Concentration
A-SMA (1A4) Sigma A2547 WB 1:10,000
b-actin Sigma A5441 WB 1:10,000
b-tubulin Sigma T4026 WB 1:2000
CD31 Abcam ab28364 IF 1:100
CD45 BD Biosciences 550539 IF 1:100
Collagen 1a1 EMD Millipore AB765P IF 1:200
DDR2 CST 12133 WB 1:1000
FAP EMD Millipore ABT11 IF 1:100
Integrin b1 BD Biosciences 552828 IF 1:50
Integrin b1 CST 4706 WB 1:500
Integrin b1 (9EG7) BD Biosciences 553715 IF 1:50
K14 Covance PRB-155P IF 1:100
K8 DSHB TROMA-1 IF 1:100
p-MLC (Ser19) CST 3671 IF 1:50
PDGFRa-FITC eBioscience 11-1401-80 FACS 1:50
Rap1 EMD Millipore 07–916 WB 1:500
Talin1 (8D4) Sigma T3287 IF, WB 1:250, 1:2000
Vinculin Sigma V9131 IF 1:250
DOI: https://doi.org/10.7554/eLife.45508.019
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vanadate, 1 mM sodium fluoride, and 10 mg/ml each aprotinin and leupeptin. Equal amounts of pro-
tein were pre-cleared with Protein G Sepharose beads and then incubated with talin1 antibody over-
night with gentle agitation. Protein G Sepharose beads were added for 1 hr at four degrees, then
beads were washed four times with Co-IP buffer, resuspended in 2X Laemmli sample buffer, boiled,
and separated by SDS-PAGE.
RAP1 activation assay
For RAP1-GTP immunoprecipitation, we followed the manufacturer’s instructions (EMD Millipore 17–
321). Briefly, cells were serum starved overnight and then plated on collagen coated tissue culture
dishes for 15 min. They were lysed in the supplied lysis buffer supplement with 1 mM PMSF, 1 mM
sodium vanadate, 1 mM sodium fluoride, and 10 ug/ml each aprotinin and leupeptin. Samples were
sheared with passages through 27G needle, spun, and supernatants incubated with RAL-GDS-RBD
agarose beads at 4 degrees for 45 min. Beads were washed and resuspended in 2X Laemmli buffer,
boiled, separated by SDS-PAGE, and then Western blotted with anti-RAP1 antibodies.
Traction force measurement
Glass coverslips were activated with 3-APTMS for 5 min and fixed in 0.5% glutaraldehyde for 30 min
at room temperature. Hydrophobic coverslips were made by treatment with Sigmacote. Soft (792
Pa) polyacrylamide hydrogels were made by polymerizing (final concentrations of 5% acrylamide and
0.1% bis-acrylamide with 0.5% dark red fluorescent beads, 0.2 um; Thermo Fisher Scientific F8807)
gel in a sandwich between the functionalized and hydrophobic coverslips. Gels were allowed to
polymerize for 30 min at room temperature, the sandwich separated and washed. The surface of the
gel was functionalized with 0.5 mg/mL sulfo-SANPAH in 50 mM HEPES, pH 8.2 under UV light for 10
min. Gels were extensively washed and then incubated with 50 ug/mL collagen 1 in 50 mM HEPES,
pH 8.2 overnight at four degrees Celsius. The next day, gels were washed and equilibrated in
DMEM. Cells were plated sparsely and allowed to adhere and spread overnight. During microscopy,
cells were kept at 37 degrees and under 5% CO2 in an incubated plate holder. Images were taken
before and after trypsinization, and bead displacements calculated with a Matlab program.
Super resolution microscopy
For collagen coating, 50 ug/mL collagen in water was spread on 12 mm glass coverslips (no. 1.5,
high precision) and allowed to dry at room temperature overnight. The next day, the coverslips were
blocked with 1% BSA in PBS for 1 hr at room temperature and sterilized under UV for 20 min. Cells
were serum starved and removed from tissue culture plates non-enzymatically. They were then
sparsely plated (1  104 per coverslip) and allowed to adhere and spread for indicated times. Cells
were then fixed in 4% paraformaldehyde for 15 min at room temperature. Cells were permeabilized
in 0.1% Triton X-100 in PBS for 5 min at room temperature, washed with PBS, and blocked with 5%
normal goat serum in PBS. Primary antibodies were added and incubated at four degrees Celsius
overnight. Coverslips were washed and secondary fluorescent antibody added for 1 hr at room tem-
perature. Coverslips were washed again and mounted in Prolong Diamond mounting medium. Cov-
erslips were allowed to cure for 24 hr. For focal adhesion quantification, cells were imaged by
confocal microscopy on NIS-Elements software (Nikon A1Rsi, inverted). Z-stacks were taken with a
step size of 0.2 um with a 40X objective. Z-stacks were flattened by maximum intensity projection,
and focal adhesions were quantified in ImageJ by subtracting the background, thresholding to the
same level for all samples, and running particle analysis. For n-SIM super-resolution microscopy,
images were taken with NIS-Elements software on a Nikon Ti-E microscope with a high NA 100X
objective. Fluorescence was captured with an Andor Zyla 4.2 Megapixel sCMOS camera. Z-stacks
were taken for all images with a step size of 0.15 um. n-SIM images were reconstructed in NIS-Ele-
ments, and fluorescence intensity co-localization quantification was done in ImageJ. For use of spe-
cific antibodies see Table 1.
Mouse tumor/metastases assays
Spontaneous genetic model
The conditional Ddr2 floxed allele was generated as previously described (Corsa et al., 2016). This
allele was crossed to FSP1cre; MMTV-PyMT mice to generate FSP1cre; Ddr2fl/fl; MMTV-PyMT mice.
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Wild type littermates were used as controls. All genotyping was done on DNA from mouse tails.
DNA was extracted and PCR run using KAPA Biosystems HotStart PCR (KK5621). For primers used
see Table 2. FSP1cre mice, on an FVB/n background, were from the Dr. Zena Werb (San Francisco,
CA). Tumor bearing mice were monitored weekly until end stage (a single tumor of 2 cm), typically
18–20 weeks. Mice were euthanized and primary tumors and lungs collected. All mice analyzed
were >90% FVB/n. Lungs were fixed overnight in 10% neutral buffered formalin and then embedded
in paraffin. Three 5 um sections were taken 200 mm apart per lung and stained with hematoxylin and
eosin. Metastases were counted in all lobes and documented as average number of total lung
metastases.
Orthotopic transplant model
8 week old female Ddr2+/+ or ubiquitous Ddr2-/- (on a Balb/C background >6 generation) received
breast transplants (mammary fat pad) of 106 4T1 breast tumor cells (Balb/C and express DDR2).
After 2 weeks primary tumor volume was determined at autopsy and number of lung tumors per
slice from all five lobes identified and counted histologically.
Lung colonization assay
106 primary PyMT breast tumor cells or 105 4T1 breast tumor cells were injected I.V. (tail vein) into
respective syngeneic mice. After 2 or 1 week, respectively, the number of lungs tumors were identi-
fied and enumerated histologically.
Tumor immunofluorescence
Tumors were dissected away from the skin and then cut into <1 cm pieces to allow efficient fixation.
Tumors were fixed overnight in 10% neutral buffered formalin and then equilibrated in 30% sucrose
overnight at four degrees. Equilibrated tissues were embedded in OCT and cryosectioned at 5–10
um per section. Sections were post-fixed in 4% paraformaldehyde for 15 min, permeabilized in 0.1%
Triton X-100 for 5 min. and blocked in 5% goat serum for 1 hr at room temperature with washes in
1X PBS in between each step. Primary antibodies were incubated overnight at four degrees. Sec-
tions were then washed twice with 1X PBS and secondary antibody added for 1 hr at room tempera-
ture. Sections were then washed four times in 1X PBS, mounted in VectaShield with DAPI (VWR,
101098–044), and sealed with nail polish. Images were taken on an inverted Nikon epifluorescence
microscope. Brightness and contrast adjustment as well as co-staining quantification was done man-
ually in ImageJ. For use of specific antibodies see Table 2.
Mouse tumor organoid isolation, culture, and analyses
Tumor bearing mice were monitored weekly and euthanized at 12 weeks. All mice were used in com-
pliance with the Washington University Institutional Animal Care and Use Committee under protocol
#20150145. Mice mammary tumor organoids were obtained as previously described (Corsa et al.,
Table 2. Primer sequences for DDR2 mouse genotyping.
Name Sequence (5’ – 3’)
FRT 5’ Fwd CTGTGTCTCTGGCTCAAAGTGTC
Targeted exon Rv CCTTCCCAAGGCAGACCATTC
PyMT Fwd GGAAGCAAGTACTTCACAAGGG
PyMT Rv GGAAAGTCACTAGGAGCAGGG
Cre Fwd GCATTACCGGTCGATGCAACGAGTGATGAG
Cre Rv GAGTGAACGAACCTGGTCGAAATCAGTGCG
ROSA-LSL-TdTomato Fwd GAGGGCCGCCACCACCTGTTCCTGTACGG
ROSA-LSL-TdTomato Rv ATGATACAAAGGCATTAAAGCAGCGTATCC
ROSA-WT Fwd GGGGAGTGTTGCAATACCTTTCTGGGAGTTC
ROSA-WT Rv AAAACCGAAAATCTGTGGGAAGTCTTGTC
DOI: https://doi.org/10.7554/eLife.45508.018
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2016), mixed with 2 mg/ml collagen I solution, loaded into the middle tissue chamber of a microflui-
dic device, allowed to polymerize (37˚C, 20% O2), and media (DMEM, 10% FBS, P/S) was delivered
to the top and bottom fluidic lines and cultured in 5% O2 for 48 hr. All immunostaining was per-
formed with organoids maintained within the devices, and all reagents were delivered via microflui-
dic lines. After fixing and blocking, organoids were stained for 9EG7, total Integrin b1, and FAP; all
primary antibody staining was incubated overnight at 4C. Species-specific secondary antibodies (488
or 566 wavelength) and nuclei staining (DAPI) were also used. Imaging was performed via confocal
microscopy (Zeiss, 63X). Analysis was performed using FIJI to quantify fluorescence (corrected total
cell fluorescence (CTCF) = Integrated Density – (Area of selected cell X Mean fluorescence of back-
ground readings)) in the entire tumor organoid as well as in FAP positive cells only.
Second harmonic generation and TACS scoring
10 to 12 week old tumors were dissected and fixed in 10% neutral buffered formalin overnight at
room temperature. They were then embedded in paraffin and sectioned in 5–10 um sections. In
some cases, sections were stained with H and E, picosirius red, or trichrome stain prior to SHG imag-
ing. Prior staining had no effect on SHG signal. Images were acquired on a Zeiss LSM 880 Airyscan
confocal microscope using an inverted, motorized Zeiss Axio Observer Z1 frame. Two-photon
images were collected at 880 nm, using non-descanned detectors set to 440 nm for SHG. Three to
four z-stacks were acquired (step size 2 um) per tumor. The z-stacks were compressed and TACS sig-
nature was scored by three blinded reviewers as previously described (Corsa et al., 2016)
(Provenzano et al., 2006).
Focused ion beam scanning electron microscopy (FIB-SEM)
Mice were perfused with pre-warmed, 37-degree, Ringer’s solution (155 mM NaCl, 3 mM KCl, 2 mM
CaCl2, 1 mM MgCl2, 3 mM NaH2PO4, 5 mM HEPES, pH 7.4, 10 mM glucose) for 2 min and then for
5 min with pre-warmed, 37-degree fixative (2.5% glutaraldehyde, 2% paraformaldehyde, 0.05%
ruthenium red, 0.2% tannic acid in 0.15M cacodylate). Tumors were then dissected out and placed
in fixative for 15 min at 37 degrees, then four degrees overnight. Samples were embedded in resin
and scanned by FIB-SEM.
Atomic Force Microscopy
Non-necrotic 10 to 12 week old tumors were gently dissected away from the skin and flash frozen in
OCT. Tumors were sectioned at 20 mm per section. Just prior to AFM, tissues were quickly thawed
in 1XPBS at room temperature and then maintained in 1X PBS supplemented with protease inhibitor
cocktail (Roche Diagnostics, 11836170001) and propidium iodide (20 mg/ml). 5–6 force maps were
taken of at least two tumors from three mice per group. AFM was performed as described
(Acerbi et al., 2015). All indentations were taken on an MFP-3D-BIO AFM (Asylum Research)
mounted on an Olympus X711 inverted fluorescent microscope in an TMC acoustic noise enclosure.
We used silicon nitride cantilever tips with a 5 mm borosilicate glass sphere affixed to the tip with a
spring constant of 0.06 N/m (Novascan, Boone, IA). The cantilever was calibrated with thermal oscil-
lation prior to each experiment. Indentations were taken at 20 um/second loading-rate with a maxi-
mum force of 5 nN, and force maps were generated using the FMAP function on IGOR software
(Asylum Research). The Hertz method was used to calculate elasticity and Poisson’s ratio of 0.5 was
used to calculate Young’s elastic modulus.
Statistical analysis
P-values were calculated using either Student’s unpaired, two-tailed T-Tests or ANOVA with Tukey’s
post hoc, as noted in figure legends.
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